Quent Capital’s Clovis Oncology, Inc. CLVS Stock Holding History

Quent Capital’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-231	Closed	-$12	–	1357
2022 Q4	$12	Hold	231	–	–	﹤0.01%	1314
2022 Q3	$0	Hold	231	–	–	﹤0.01%	1302
2022 Q2	$0	Hold	231	–	–	﹤0.01%	1360
2022 Q1	$0	Buy	+231	New	+$454	﹤0.01%	1341

Other funds holding CLVS

RMC

Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Quent Capital's CLVS Position: Q1 2023 in Review

Quent Capital sold out of Clovis Oncology, Inc. (CLVS) in Q1 2023, closing a stake of 231 shares — an estimated $12 sold.

Quent Capital first reported a position in CLVS in Q1 2022 and held it in 4 quarters. The position peaked at $12 in Q4 2022. 2 funds tracked by Wall St. Rank hold CLVS as of Q1 2023.

Quent Capital reported no remaining Clovis Oncology, Inc. position as of Q1 2023 after selling out during the quarter.
Quent Capital sold 231 Clovis Oncology, Inc. shares in Q1 2023, an estimated $12.
Quent Capital first reported a position in Clovis Oncology, Inc. in Q1 2022 and held it in 4 quarters.
Quent Capital's Clovis Oncology, Inc. position peaked at $12 in Q4 2022.
2 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2023.

Based on Quent Capital's 13F filing for Q1 2023, filed 6 Apr 2023.